Nearly $500 million dollars has recently flooded into the coffers of psychedelic drug companies. That's enough capital to power a lot of growth.
Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial
Numinus' Vancouver clinic will be used for collaboration on a clinical trial with MAPS for MDMA-assisted therapy for PTSD.
Mind Cure Announces Eligibility for DTC Trading
Mind Cure stock is now much more easily accessible for U.S.-based investors.
Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021
Entheon announces an agreement for the purpose of conducting a Phase 1 clinical trial.
Feeding Frenzy On Red-Hot Psychedelic Stocks
Psychedelic stocks just finished one of their most-explosive trading week yet. But there are good reasons to expect that the best is yet to come.
The Psychedelics Revolution: It’s No Longer BAD To Feel GOOD
A Psychedelic Drug Revolution is occurring -- to bring badly needed psychedelic medicines to a world suffering from a Mental Health Crisis.
Entheon Biomedical to Begin Trading on the Frankfurt Exchange
Entheon adds a German listing to its original CSE listing.
MindMed Upsizes Previously Announced Bought Deal Public Offering
MindMed's CAD$25-million bought deal financing becomes a $30 million financing -- the same day.
MindMed Announces 2nd $25 Million Bought Deal Public Offering
MindMed's most recent financing is at nearly double where it priced units just 6 weeks earlier.
MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines
MindMed launches its digital medical division.
Why An ATAI IPO Is Driving MindMed Stock
ATAI Life Sciences is going public. MindMed Inc is hitting new highs. The two events ARE connected.
Novamind Closes Oversubscribed CAD$10 Million Private Placement
Novamind has closed on double its original target (CAD$5 million). Preparing to commence trading on the CSE (symbol "NM").
